Supply of Proprietary Reagents and Controls (QuantiFERON TB Gold Plus Kits)

The contract pertains to the exclusive supply of proprietary diagnostic reagents, controls, and consumables manufactured by DiaSorin for use in LIAISON® TB testing systems at the VA Medical Center. These materials are specifically designed for the QuantiFERON TB Gold Plus Kits, ensuring compatibility and optimal performance within the designated diagnostic platform. The agreement mandates that all products be sourced directly from DiaSorin, maintaining strict adherence to proprietary specifications and quality control standards required for accurate tuberculosis detection. This subcontract, issued under the Department of Veterans Affairs through the 247-NETWORK Contract Office 7, is open for response until July 13, 2026, with a posted date of June 30, 2026. The North American Industry Classification System code 325414 indicates classification within the in-vitro diagnostic substance manufacturing sector. The place of performance and organizational details are not specified, but the contract is structured to support diagnostic operations at VA medical facilities. No set-aside provisions are indicated, and the contract is intended to ensure a reliable, uninterrupted supply chain for critical TB testing materials within the VA healthcare network.